Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Killian S Hanlon

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|April 17, 2021
Delivering AAV to the Central Nervous and Sensory SystemsCole W Peters, Casey A Maguire, Killian S Hanlon
Frontiers in Neuroscience|October 7, 2017
A Novel Retinal Ganglion Cell Promoter for Utility in AAV VectorsKillian S Hanlon, Naomi Chadderton, Arpad Palfi, et al.
Scientific Reports|March 13, 2020
In vivo engineering of lymphocytes after systemic exosome-associated AAV deliveryCort B Breuer, Killian S Hanlon, Jeya-Shree Natasan, et al.
Scientific Reports|October 6, 2020
Novel 199 base pair NEFH promoter drives expression in retinal ganglion cellsSophia Millington-Ward, Naomi Chadderton, Megan Berkeley, et al.
Hearing Research|March 9, 2020
Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochleaMaryna V Ivanchenko, Killian S Hanlon, Maya K Devine, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
AAV-S: A versatile capsid variant for transduction of mouse and primate inner earMaryna V Ivanchenko, Killian S Hanlon, Daniel M Hathaway, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Frontiers in Molecular Biosciences|December 7, 2020
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor ProgressionThomas S van Solinge, Erik R Abels, Lieke L van de Haar, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|April 17, 2021
Delivering AAV to the Central Nervous and Sensory SystemsCole W Peters, Casey A Maguire, Killian S Hanlon
Frontiers in Neuroscience|October 7, 2017
A Novel Retinal Ganglion Cell Promoter for Utility in AAV VectorsKillian S Hanlon, Naomi Chadderton, Arpad Palfi, et al.
Scientific Reports|March 13, 2020
In vivo engineering of lymphocytes after systemic exosome-associated AAV deliveryCort B Breuer, Killian S Hanlon, Jeya-Shree Natasan, et al.
Scientific Reports|October 6, 2020
Novel 199 base pair NEFH promoter drives expression in retinal ganglion cellsSophia Millington-Ward, Naomi Chadderton, Megan Berkeley, et al.
Hearing Research|March 9, 2020
Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochleaMaryna V Ivanchenko, Killian S Hanlon, Maya K Devine, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
AAV-S: A versatile capsid variant for transduction of mouse and primate inner earMaryna V Ivanchenko, Killian S Hanlon, Daniel M Hathaway, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1FCole W Peters, Killian S Hanlon, Maryna V Ivanchenko, et al.
Frontiers in Molecular Biosciences|December 7, 2020
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor ProgressionThomas S van Solinge, Erik R Abels, Lieke L van de Haar, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Pageof 2